This toolkit was developed by ChangeLab Solutions, the Centers for Disease Control and Prevention (CDC), the National Alliance of State Pharmacy Associations (NASPA) and the American Pharmacists Association (APhA) as part of a cooperation agreement with ChangeLab Solutions. (3) “cooperation agreement”: a written agreement or protocol between one or more pharmacists and one or more physicians providing for the management of collaborative drug therapy. This agreement on collaborative practice must contain certain conditions or restrictions, in accordance with the order, permanent appointment, delegation or protocol of the cooperating physician. A Community practice agreement is as follows: (A) in accordance with the doctor`s usual specialty, skills and legal practice; and (B) depending on the pharmacist`s training and experience. (2) Persons who insert words or abbreviations in their names indicating that they are a licensed pharmacist for the practice of a pharmacy in Kansas. The act makes several changes to the Kansas Pharmacy Act. It adds definitions of “collaborative management of drug therapy,” “collaborative practice convention,” “pharmacy practice” and “physician” to national pharmacy law; Clarifies restrictions on reloading prescriptions; and creates the Drug Drug Therapy Management Collaborative Advisory Committee, based on a summary of legislation from the Kansas Department of Legislative Research, made available by the Kansas Pharmacists Association (KPhA). (2) “collaborative drug therapy management” refers to a pharmacy practice in which a pharmacist performs certain pharmaceutical care functions for a given patient, which have been delegated by the physician to the pharmacist by a community practice agreement. A physician who enters into a collaborative practice agreement is responsible for the management of the patient after a first diagnosis and assessment, as well as the management and management of the pharmacist throughout the management process of community drug therapy. Nothing in this subsection should be designed to allow a pharmacist to change a physician`s instructions, diagnose or treat a disease, prescribe medication independently, or practice medicine and surgery independently. b) 1) “pharmaceutical practice”: the interpretation and evaluation of prescription orders; compounding, measuring and labeling drugs and devices in accordance with prescription regulations; Administering vaccines in accordance with a vaccination protocol; participation in drug selection in accordance with state law and participation in drug use controls; proper and safe storage of prescription drugs and medically prescribed devices and the maintenance of medically prescribed records, in accordance with the law; consult patients and other physicians on the safe and effective use of prescription drugs and medically prescribed devices; Implementation of collaborative drug therapeutic management, in accordance with a written cooperation agreement with one or more physicians with an established relationship between physician and patient; and participate in the execution or execution of these acts, services, operations or transactions necessary for the realization, operation, management and control of a pharmacy.

Nothing in this section can be interpreted in such a way that additional requirements are required for registration or authorization in accordance with the Kansas State Pharmacy Act, or for the authorization provided by the subsection (g) of K.S.A. 65-1643 and their modifications, or to prevent persons other than pharmacists from conducting an audit of the use of the drug. , or for persons legally in possession of medicines or medically prescribed devices. , is required to meet all retention or registration requirements, with the exception of these retention and registration requirements, which may be provided by law or concern a person who consults a physician on the safe and effective use of prescription drugs or devices.